NCT04234113 2026-03-27Study of Nanrilkefusp Alfa Alone and With Pembrolizumab in Adult Patients With Advanced/Metastatic Solid TumorsSotio Biotech Inc.Phase 1 Terminated115 enrolled 43 charts
NCT06048367 2025-08-03CNSI-Fe(II)Sichuan Enray Pharmaceutical Sciences CompanyPhase 1 Completed19 enrolled 47 charts
NCT03127098 2024-08-06QUILT-3.040: ETBX-011 (Ad5 [E1-, E2b-]-CEA(6D)) Vaccine in Combination With ALT-803 (Super-agonist IL-15) in Subjects Having CEA-Expressing CancerNantCell, Inc.Phase 1/2 Terminated3 enrolled 6 charts
NCT02988817 2023-08-01Enapotamab Vedotin (HuMax-AXL-ADC) Safety Study in Patients With Solid TumorsGenmabPhase 1/2 Completed306 enrolled 51 charts